Asston Pharmaceuticals IPO
ListedQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Asston Pharmaceuticals IPO Details
-
Bidding Date
09-Jul-2025 to
11-Jul-2025 -
Issue Size
₹27.56 Cr
-
Price Band
₹115 to ₹123
-
Allotment date
14-Jul-2025
-
Listing date
16-Jul-2025
-
Lot size
1000
-
No. of shares
22,41,000
-
Fresh issue/OFS
₹27.56 Cr /--
About Asston Pharmaceuticals Company
Established in 2019, Asston Pharmaceuticals Limited is a growing pharmaceutical and nutraceutical manufacturer focused on both domestic and export markets, especially in Africa. Operating under the brand “Asston,” the company develops and markets a broad portfolio of formulations including tablets, capsules, syrups, creams, gels, sachets, and suspensions. It caters to global demand through direct sales and contract manufacturing arrangements, supported by a WHO-GMP certified facility in Ambernath, Maharashtra. The facility maintains dedicated production zones for pharmaceuticals and nutraceuticals, producing up to 9 crore tablets monthly. Beyond manufacturing, Asston also provides formulation expertise to contract partners and oversees a robust export network spanning over 10 countries.
Subscription Status
-
Category
Status
-
QIBs
85.8x
-
NIIs
261.6x
-
Retail
171.8x
-
Others
--
-
Total
173.4x
FAQs for Asston Pharmaceuticals IPO.
What is the issue size of Asston Pharmaceuticals IPO?
The issue size of Asston Pharmaceuticals is ₹27.56 Cr.
What is the industry of Asston Pharmaceuticals?
Asston Pharmaceuticals falls into Pharmaceuticals industry.
Where Asston Pharmaceuticals IPO will be listed?
The Asston Pharmaceuticals IPO will be listed on NSE.
What are the open and close dates for the Asston Pharmaceuticals IPO?
The open and close dates for the Asston Pharmaceuticals are 09-Jul-2025 & 11-Jul-2025.
What are the price band for Asston Pharmaceuticals IPO?
The price band for the Asston Pharmaceuticals ipo is ₹115 to ₹123
What is the listing date of Asston Pharmaceuticals IPO?
The listing date of Asston Pharmaceuticals IPO is 16-Jul-2025.
What is the purpose for the Asston Pharmaceuticals IPO?
The purpose of this IPO is to raise fresh capital.
How much times Asston Pharmaceuticals IPO subscribed?
Asston Pharmaceuticals total subscription ratio is 173.4X.
What are the key financials for the Asston Pharmaceuticals IPO?
Key financial of the Asston Pharmaceuticals are:
| Asston Pharmaceuticals | FY-25 | FY-24 | FY-23 | FY-22 |
|---|---|---|---|---|
| Revenue (₹ Cr) | 25.04 | 15.59 | 6.54 | 9.6 |
| EBIT (₹ Cr) | 6.08 | 2.5 | 1.48 | -0.36 |
| Proft after Tax (₹ Cr) | 4.33 | 1.36 | 1.06 | 0.11 |
| Debt (₹ Cr) | 7.26 | 6.82 | 5.25 | 3.31 |
| Net Worth (₹ Cr) | 10.72 | 6.39 | 1.99 | 0.93 |
| RoE (%) | 40.35 | 21.28 | 53.21 | 11.9 |